Medical Excellence Capital — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

SonoTherasonothera.com in 𝕏Jun 2026

SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.

BiotechDeep TechDigital HealthHealthtechSouth San Francisco, US

Kenneth Greenberg(Co-Founder, President & CEO)in

Co-investorsVida Ventures Leaps by Bayer ARCH Venture Partners Foothill Ventures Illumina Ventures Vivo Capital +8 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.